Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

155.48 +2.09 (+1.36%)
Streaming Delayed Price Updated: 11:24 AM EDT, Oct 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Momentum Model For Trading SMID Biotech Stocks: Broad Rally Underway
Biotech stocks are poised for a recovery in a seasonally strong period through January 2025. 
Via Talk Markets
Topics ETFs Stocks / Equities
Major Sector ETFs - Retail Rallies
What we waited for was a weekly close over 79.20, a level we have not seen since February 2022. 
Via Talk Markets
Topics Cryptocurrencies ETFs
Is Biotech’s Bull Run Over? Examining Election Impacts
The biotech sector's breakout attempt post-election reversed sharply, with ETFs like IBB and XBI falling and invalidating the long-term bullish setup. 
Via MarketBeat
Topics ETFs Government
Cameco, Applied Digital, West Pharmaceutical And More On CNBC's 'Final Trades'
On CNBC's "Halftime Report Final Trades," Tim Seymour of Seymour Asset Management picked Cameco Corporation. 
Via Benzinga
Reality Sets Into The Major Sector ETFs
XRT failed to rally above the $80 level, the top of the 10-month consolidation. 
Via Talk Markets
What Do Major Sector ETFs Say Now?
KRE is back to the scene of the crime at the 65 level. Above there, we see 75 area as the next resistance. 
Via Talk Markets
Topics ETFs
What Does the Economic Modern Family Say Now?
Considering where the Economic Modern Family was just a few weeks ago, clearly euphoria has spread since the election. 
Via Talk Markets
Smaller Cap Biotechs Are In Season: How Are We Doing?
SMID biotech stocks still see a lot of speculative interest except for a brief sell-off on August 5 when the XBI touched $91.The XBI is near its 2024 high in the $103 range. 
Via Talk Markets
Stock And Commodity Market Thoughts
As the SPY corrects a bit from the recent run up to all-time highs, we still have keen eyes on other sectors. 
Via Talk Markets
Healthcare Sector Update: Choppy Days Are Here Again As Yields Rise
There has been a shift in healthcare stock performance by sub-sector which should be confirmed as we move through the Q3 earnings cycle. 
Via Talk Markets
Can Biotechnology Make A Seasonal Move Higher?
Currently, IBB trades beneath the July calendar range high. 
Via Talk Markets
Did the Economic Modern Family Really Go Anywhere?
​​​​​​​After rising yields and a big drop in TLT, the trend may have reversed. Here is why that is important... 
Via Talk Markets
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
Key Index And Sectors Are Inside Last Week’s Range
The ultimate technical pattern that represents indecision is when by midweek, the price range remains stuck inside the trading pattern of the week prior. 
Via Talk Markets
Biotech Stocks Poised For Another Big Move In Q4
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
Biotech Stocks : Are You A Trader Or A Longer Term Investor?
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
Via MarketBeat
Topics ETFs Economy
Biotech Breakout: Stocks for Your Watchlist
The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150. 
Via MarketBeat
Topics ETFs
The S&P 500 Surges As “Shiny Objects” Distract Investors
The big index was up nicely today. Verizon (VZ) and Nvidia led the way as Apple (AAPL) failed to dazzle with its product-line reveal. 
Via Talk Markets
Topics Stocks
Economic Modern Family-The Good, Bad and Ugly
When we examine the weekly charts, we see a return to August lows possible. We see a return to May lows as a gift. Let's take a deeper dive... 
Via Talk Markets
Market Thoughts This Labor Day Weekend
For this long weekend, I am offering you food for thought. In the overall macro theme, I am sticking to this for time being: Stagflation - The Fed can’t fix it with a huge reduction in rates, that will... 
Via Talk Markets
Topics Economy
3 ETFs for Growth Investors to Buy and Hold for Decades
These exchange-traded funds can help you easily tap into some promising growth opportunities. 
Via The Motley Fool
Topics ETFs
Did Granny Retail And Buffett Save The Equities Market?
XRT told us a lot after the economic data already out earlier in the week (CPI PPI), and then the retail sales and earnings reports that came out today. 
Via Talk Markets
ETFs Where Are They Now?
Did this past week really resolve which way the Modern Family wants to go from here? In some ways yes and other ways no. 
Via Talk Markets
Topics ETFs
Divided We Stood, United We Fall
Considering the bifurcation of the sectors and that the Long Bonds TLT were already flashing risk off, this week’s unified selling comes as no surprise. 
Via Talk Markets
Monday Quarterbacking The Major Sector ETFs
All but Retail XRT. But XRT only garnered a rally early in the day and settled within last week’s range. 
Via Talk Markets
Healthcare Stocks Are Coming On Strong In July Led By Biotech
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
The 3 Best ETFs to Buy for the Small-Cap Revival
With the Street starting to become enthusiastic about small-cap stocks,, here are the three best small-cap ETFs to buy. 
Via InvestorPlace
Topics ETFs
The Long Bonds Update
Should TLT clear July highs, we see a potential shift in the landscape with fears of recession starting to emerge. 
Via Talk Markets
Topics Economy
Biotech Bull Market Is Intact But SMIDs Are Too Volatile
It was another wild week for the market as it had to contend with a lot of news. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.